Area of research
Oncology · Statistics, Probability and Uncertainty
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Risk and Safety Analysis, CAR-T cell therapy research, and Brain Metastases and Treatment.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Melanoma and immunotherapy bridge 2015
Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases.